Discover how cfDNA fragmentome tests could help detect liver disease early and track health. Learn more about this emerging ...

Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...

Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI - ...

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...

Artificial intelligence is rapidly transforming health care. AI systems can now detect diabetic eye disease from retinal photos and analyze CT images for signs of early-stage lung cancers and stroke.

Objective A panel of antibodies against three antigens, University Hasselt (UH)-rheumatoid arthritis (RA).305, 318 and 329, has been associated with lack of response to first-line therapy in the Care ...

PECOTA, which stands for Player Empirical Comparison and Optimization Test Algorithm, is BP’s proprietary system that projects player and team performance PECOTA is a system that takes a player’s past ...